Episode 33: Exploring Multi-Cancer Early Detection: Understanding the Science Behind the Galleri Test
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Episode 33: Exploring Multi-Cancer Early Detection: Understanding the Science Behind the Galleri Test
-
Lu par :
-
De :
À propos de ce contenu audio
Join host Nicholas O. Biasotto, DO, for an insightful conversation with Lara Bagby, Board-Certified Genetic Counselor and Field Medical Director at GRAIL, as they discuss the science and clinical concepts behind the Galleri Test, a multi-cancer early detection screening that analyzes cell-free DNA for cancer signals.
In this episode, listeners will learn about key terms such as cell-free DNA, cancer fingerprint, binary results, and negative predictive value. They explore how this test fits into the broader landscape of cancer screening, who may qualify for testing, and important considerations such as risk factors and insurance coverage.
Note: At the time of this publication, the podcast, its host, and the Medical Society of Delaware encourage patient education and consultation with a qualified health care professional before pursuing any testing or procedures. The Galleri Test is not FDA-approved. This discussion is for educational purposes only and should not be interpreted as an endorsement or recommendation.
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !